J9341 Thiotepa (tepylute) - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Thiotepa (tepylute)

Brand Name:

Tepylute

Strength:

1mg

HCPCS:

J9341

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Alkylating Agent

Minor Drug Class:

Nitrogen Mustard /Ethylenimine

Oral (Y/N):

No

FDA Approval Year:

2025

FDA Discontinuation Year:

CMS Effective Date:

July 9, 2025

CMS Discontinuation Date:

Status:

In Use